ECOG-ACRIN Cancer Research Group shared a post on X:
“Dr. Amer Zeidan of Smilow Cancer Hospital and Yale Cancer Center is leading clinical study EA9171, testing if adding a new drug to the usual treatment for chronic myelogenous leukemia could help patients. Learn more here.”